119 related articles for article (PubMed ID: 36585882)
1. The Impact of HLA-G and HLA-E Polymorphisms on CMV Reinfection in Liver Transplant Recipients.
Darai M; Soleimanian S; Yaghobi R; Kazemi K; Nikeghbalian S; Azarpira N
Iran J Immunol; 2022 Dec; 19(4):404-413. PubMed ID: 36585882
[TBL] [Abstract][Full Text] [Related]
2. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
[TBL] [Abstract][Full Text] [Related]
3. 14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation.
Thude H; Janssen M; Sterneck M; Nashan B; Koch M
Hum Immunol; 2016 Dec; 77(12):1159-1165. PubMed ID: 27664842
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
[TBL] [Abstract][Full Text] [Related]
5. Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation.
Guberina H; Tomoya Michita R; Dolff S; Bienholz A; Trilling M; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113092
[TBL] [Abstract][Full Text] [Related]
6. HLA-G polymorphism (rs16375) and acute rejection in liver transplant recipients.
Azarpira N; Aghdaie MH; Kazemi K; Geramizadeh B; Darai M
Dis Markers; 2014; 2014():814182. PubMed ID: 24591768
[TBL] [Abstract][Full Text] [Related]
7. Association of cytomegalovirus genotype with graft rejection after liver transplantation.
Rosen HR; Corless CL; Rabkin J; Chou S
Transplantation; 1998 Dec; 66(12):1627-31. PubMed ID: 9884250
[TBL] [Abstract][Full Text] [Related]
8. The effect of genetic variants affecting NK cell function on cardiovascular health and the burden of CMV.
Waters S; Lee S; Affandi JS; Irish A; Price P
Hum Immunol; 2017 Nov; 78(11-12):747-751. PubMed ID: 28987961
[TBL] [Abstract][Full Text] [Related]
9. Donor derived HLA-G polymorphisms have a significant impact on acute rejection in kidney transplantation.
Janssen M; Thaiss F; Nashan B; Koch M; Thude H
Hum Immunol; 2019 Mar; 80(3):176-183. PubMed ID: 30610894
[TBL] [Abstract][Full Text] [Related]
10. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
[TBL] [Abstract][Full Text] [Related]
12. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3'UTR 14 bp polymorphism and sHLA-G.
Darbas S; Yilmaz VT; Kocak H; Kisaoglu A; Demiryilmaz I; Aydinli B; Arslan HS; Ucar F
Gene; 2021 Jul; 790():145712. PubMed ID: 33984446
[TBL] [Abstract][Full Text] [Related]
13. HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications.
Piancatelli D; Maccarone D; Liberatore G; Parzanese I; Clemente K; Azzarone R; Pisani F; Famulari A; Papola F
Transplant Proc; 2009 May; 41(4):1187-8. PubMed ID: 19460512
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Plasma Levels of Soluble HLA-G and HLA-G Genotypes in Kidney Transplant Recipients.
Piancatelli D; Maccarone D; Colanardi A; Sebastiani P; D'Anselmi F; Iesari S; Binda B; Pisani F
Transplant Proc; 2020 Jun; 52(5):1559-1561. PubMed ID: 32217007
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients.
Sarcinella L; Mazzulli T; Willey B; Humar A
J Clin Virol; 2002 Feb; 24(1-2):99-105. PubMed ID: 11744434
[TBL] [Abstract][Full Text] [Related]
16. Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome.
Durmanova V; Bandzuchova H; Zilinska Z; Tirpakova J; Kuba D; Buc M; Polakova K
Immunol Invest; 2019 Aug; 48(6):644-658. PubMed ID: 31094243
[No Abstract] [Full Text] [Related]
17. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.
Twito T; Joseph J; Mociornita A; Rao V; Ross H; Delgado DH
J Heart Lung Transplant; 2011 Jul; 30(7):778-82. PubMed ID: 21482149
[TBL] [Abstract][Full Text] [Related]
18. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
19. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome].
Roubalová K; Strunecký O; Zufanová S; Procházka B; Vitek A
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):92-9. PubMed ID: 20586171
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis versus pre-emptive treatment for prevention of cytomegalovirus infection in CMV-seropositive orthotopic liver-transplant recipients.
Mengelle C; Rostaing L; Weclawiak H; Rossignol C; Kamar N; Izopet J
J Med Virol; 2015 May; 87(5):836-44. PubMed ID: 25655981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
